Posts Tagged ‘clinical’

If there’s one list that gets a lot of touch attention in life sciences, it’s Gartner’s Cool Vendors in Life Sciences. While the name of the list helps grab attention on its own, the companies it features are typically just as interesting. This year’s list happens to carry a few companies that we’ve blogged about, […]

In a recent blog post, I mentioned the three critical themes for success in the digital age, as identified by McKinsey & Company through interviews with 20 pharma executives: 

  In a time when the turnover rate for clinical monitoring positions in the U.S. hovers around 25%, it’s more important than ever to do more with less. With risk-based monitoring (RBM), contract research organizations (CROs) and sponsors can leverage data in existing IT systems to spot, rectify, and prevent issues related to the execution […]

  Real-world data, the data generated about drugs and devices in real-world settings (e.g., routing doctor visits, hospital stays, etc.), can help develop more accurate product profiles. This is because the data comes from products that are no longer confined to the smaller, homogenous populations involved in clinical trials. More comprehensive profiles can help better […]

  In my tenure here at Perficient, I’ve contributed to a number of guides for the life sciences industry. Each one has been informative and useful, but I can’t remember ever being as excited about any of them as I am about the newest one: Life Sciences is Going Digital. 

  In less than a month, Oracle will be hosting Oracle Health Sciences Connect Europe, a free event that is geared towards users of Oracle’s life sciences applications, as well as partners of the software company. The one-day meeting will take place on March 22, 2016, in London and will provide information on product roadmaps, […]

  Dr. Robert Califf, a cardiologist who has spent most of his career at Duke University, was confirmed by the Senate on February 24, 2016, to be the next FDA commissioner, following President Barack Obama’s nomination in September 2015. 

  Now that February is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in January– they’re ranked in order of popularity, with number one being the most viewed piece. 

  Most digital transformation initiatives begin with customer journey mapping, a process that helps fully understand the dynamics of your target customer and their behavior. Journey mapping connects the dots from your customer’s initial interaction with your brand, through their entire experience with your brand via multiple channels (e.g., website, mobile app, phone call, direct […]

  An interesting thing happened in pharma and investing. It involved Regeneron and their July 24, 2015 FDA-approved cholesterol drug, Praluent. Forbes outlined the situation, which caused Regeneron stock to drop significantly, in a January 6, 2016 article. According to Matthew Herper, a Forbes columnist, investors got a hold of data from the FDA’s Adverse […]

  We’ve been getting a lot of requests, lately, to help companies decommission their old GxP systems. The systems were once validated and still contain GxP data that might someday need to be reviewed or analyzed, but they’re no longer being actively used. They’re just sitting there, taking up server space, undergoing basic IT maintenance, […]

  Gordon Ritter, co-founder and general partner of Emergence Capital, wrote an article in TechCrunch the day after Thanksgiving in which he spoke about the prowess of “industry cloud companies” – companies that develop software for specific verticals. “These companies might not be well-known outside specific industries, but ask anyone within an industry vertical and […]